BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chua KN, Poon KL, Lim J, Sim WJ, Huang RY, Thiery JP. Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept. Adv Drug Deliv Rev. 2011;63:558-567. [PMID: 21335038 DOI: 10.1016/j.addr.2011.02.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Nam SH, Kim D, Lee MS, Lee D, Kwak TK, Kang M, Ryu J, Kim HJ, Song HE, Choi J, Lee GH, Kim SY, Park SH, Kim DG, Kwon NH, Kim TY, Thiery JP, Kim S, Lee JW. Noncanonical roles of membranous lysyl-tRNA synthetase in transducing cell-substrate signaling for invasive dissemination of colon cancer spheroids in 3D collagen I gels. Oncotarget 2015;6:21655-74. [PMID: 26091349 DOI: 10.18632/oncotarget.4130] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
2 Forte E, Miraldi F, Chimenti I, Angelini F, Zeuner A, Giacomello A, Mercola M, Messina E. TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies. Stem Cells Dev 2012;21:3081-90. [PMID: 22765842 DOI: 10.1089/scd.2012.0277] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
3 Aref AR, Huang RY, Yu W, Chua KN, Sun W, Tu TY, Bai J, Sim WJ, Zervantonakis IK, Thiery JP, Kamm RD. Screening therapeutic EMT blocking agents in a three-dimensional microenvironment. Integr Biol (Camb) 2013;5:381-9. [PMID: 23172153 DOI: 10.1039/c2ib20209c] [Cited by in Crossref: 113] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
4 Germani A, Foglio E, Capogrossi MC, Russo MA, Limana F. Generation of cardiac progenitor cells through epicardial to mesenchymal transition. J Mol Med (Berl) 2015;93:735-48. [PMID: 25943780 DOI: 10.1007/s00109-015-1290-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
5 Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol. 2012;22:361-368. [PMID: 22613485 DOI: 10.1016/j.semcancer.2012.05.003] [Cited by in Crossref: 178] [Cited by in F6Publishing: 161] [Article Influence: 17.8] [Reference Citation Analysis]
6 Chua KN, Sim WJ, Racine V, Lee SY, Goh BC, Thiery JP. A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One 2012;7:e33183. [PMID: 22432005 DOI: 10.1371/journal.pone.0033183] [Cited by in Crossref: 59] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
7 Lim J, Thiery JP. Epithelial-mesenchymal transitions: insights from development. Development. 2012;139:3471-3486. [PMID: 22949611 DOI: 10.1242/dev.071209] [Cited by in Crossref: 429] [Cited by in F6Publishing: 387] [Article Influence: 42.9] [Reference Citation Analysis]
8 Li JP, Liu H, Yu JP, Yu HG. Relationship between resistance of colon cancer cells to doxorubicin and epithelial-mesenchymal transition. Shijie Huaren Xiaohua Zazhi 2014; 22(20): 2900-2904 [DOI: 10.11569/wcjd.v22.i20.2900] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Huang RY, Kuay KT, Tan TZ, Asad M, Tang HM, Ng AH, Ye J, Chung VY, Thiery JP. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120). Oncotarget 2015;6:22098-113. [PMID: 26061747 DOI: 10.18632/oncotarget.4300] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
10 Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY, Chu YS, Matsumura N, Lai HC, Lee YF, Sim WJ, Chai C, Pietschmann E, Mori S, Low JJ, Choolani M, Thiery JP. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis 2013;4:e915. [PMID: 24201814 DOI: 10.1038/cddis.2013.442] [Cited by in Crossref: 245] [Cited by in F6Publishing: 213] [Article Influence: 27.2] [Reference Citation Analysis]
11 von Gise A, Pu WT. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ Res. 2012;110:1628-1645. [PMID: 22679138 DOI: 10.1161/CIRCRESAHA.111.259960] [Cited by in Crossref: 243] [Cited by in F6Publishing: 142] [Article Influence: 24.3] [Reference Citation Analysis]
12 Huang RY, Guilford P, Thiery JP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci 2012;125:4417-22. [PMID: 23165231 DOI: 10.1242/jcs.099697] [Cited by in Crossref: 192] [Cited by in F6Publishing: 182] [Article Influence: 21.3] [Reference Citation Analysis]
13 Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21-45. [PMID: 27368099 DOI: 10.1016/j.cell.2016.06.028] [Cited by in Crossref: 1978] [Cited by in F6Publishing: 1921] [Article Influence: 395.6] [Reference Citation Analysis]
14 Zhang T, Li H, Zhang Y, Wang P, Bian H, Chen ZN. Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Oncol Lett 2018;15:3042-8. [PMID: 29435035 DOI: 10.3892/ol.2017.7701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
15 Yun-Ju Huang R, Yo-Yan Huang T. A new dimension in drug discovery: reversing epithelial-mesenchymal transition (EMT). Cell Death Dis 2016;7:e2417. [PMID: 27735942 DOI: 10.1038/cddis.2016.316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
16 Fan D, Qi P, Gao S, Chen Y, Cheng X. TGF-β1 mediates estrogen receptor-induced epithelial-to-mesenchymal transition in some tumor lines. Tumor Biol 2014;35:11277-82. [DOI: 10.1007/s13277-014-2166-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Tang HM, Kuay KT, Koh PF, Asad M, Tan TZ, Chung VY, Lee SC, Thiery JP, Huang RJ. An epithelial marker promoter induction screen identifies histone deacetylase inhibitors to restore epithelial differentiation and abolishes anchorage independence growth in cancers. Cell Death Discov 2016;2:16041. [PMID: 27551531 DOI: 10.1038/cddiscovery.2016.41] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
18 Li XT, Shen CQ, Zhang R, Shi JK, Li ZH, Liu HY, Sun B, Wang K, Yan LR. Association of TGFBR2 rs6785358 Polymorphism with Increased Risk of Congenital Ventricular Septal Defect in a Chinese Population. Pediatr Cardiol 2015;36:1476-82. [PMID: 26022443 DOI: 10.1007/s00246-015-1189-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
19 Chua KN, Kong LR, Sim WJ, Ng HC, Ong WR, Thiery JP, Huynh H, Goh BC. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma. Oncotarget 2015;6:29991-30005. [PMID: 26358373 DOI: 10.18632/oncotarget.5031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
20 Li P, Mao X, Ren Y, Liu P. Epithelial cell polarity determinant CRB3 in cancer development. Int J Biol Sci 2015;11:31-7. [PMID: 25552927 DOI: 10.7150/ijbs.10615] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
21 Zhu YC, Wang YK, Bai SJ, Zha FF, Feng G, Gao CP, Liu J. Suppression of CIP4/Par6 attenuates TGF-β1-induced epithelial-mesenchymal transition in NRK-52E cells. Int J Mol Med 2017;40:1165-71. [PMID: 28848997 DOI: 10.3892/ijmm.2017.3100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
22 Wang H, Unternaehrer JJ. Epithelial-mesenchymal Transition and Cancer Stem Cells: At the Crossroads of Differentiation and Dedifferentiation: EMT in Differentiation and Dedifferentiation. Dev Dyn 2019;248:10-20. [DOI: 10.1002/dvdy.24678] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 11.0] [Reference Citation Analysis]
23 Sun W, Lim CT, Kurniawan NA. Mechanistic adaptability of cancer cells strongly affects anti-migratory drug efficacy. J R Soc Interface 2014;11:20140638. [PMID: 25100319 DOI: 10.1098/rsif.2014.0638] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
24 Vilches-Moure JG. Embryonic Chicken (Gallus gallus domesticus) as a Model of Cardiac Biology and Development. Comp Med 2019;69:184-203. [PMID: 31182184 DOI: 10.30802/AALAS-CM-18-000061] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Yun K, Wang ZY. Target/signalling pathways of natural plant-derived radioprotective agents from treatment to potential candidates: A reverse thought on anti-tumour drugs. Biomedicine & Pharmacotherapy 2017;91:1122-51. [DOI: 10.1016/j.biopha.2017.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
26 Chimenti I, Massai D, Morbiducci U, Beltrami AP, Pesce M, Messina E. Stem Cell Spheroids and Ex Vivo Niche Modeling: Rationalization and Scaling-Up. J Cardiovasc Transl Res 2017;10:150-66. [PMID: 28289983 DOI: 10.1007/s12265-017-9741-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
27 Liang S, Li HC, Wang YX, Wu SS, Cai YJ, Cui HL, Yang YP, Ya J. Pulmonary endoderm, second heart field and the morphogenesis of distal outflow tract in mouse embryonic heart. Dev Growth Differ 2014;56:276-92. [PMID: 24697670 DOI: 10.1111/dgd.12129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
28 Sun L, Li PB, Yao YF, Xiu AY, Peng Z, Bai YH, Gao YJ. Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2018; 24(10): 1120-1133 [PMID: 29563756 DOI: 10.3748/wjg.v24.i10.1120] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
29 Tan M, Asad M, Heong V, Wong MK, Tan TZ, Ye J, Kuay KT, Thiery JP, Scott C, Huang RY. The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma. Mol Oncol 2019;13:757-80. [PMID: 30548372 DOI: 10.1002/1878-0261.12425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]